Wells Fargo
CRBU icon

Wells Fargo’s Caribou Biosciences CRBU Stock Holding History

Wells Fargo’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$577K Buy
303,655
+161,712
+114% +$278K ﹤0.01% 4079
2025
Q4 		$226K Buy
141,943
+116,089
+449% +$244K ﹤0.01% 5009
2025
Q3 		$60.2K Sell
25,854
-61,898
-71% -$117K ﹤0.01% 5499
2025
Q2 		$111K Sell
87,752
-47,128
-35% -$46.4K ﹤0.01% 5127
2025
Q1 		$123K Buy
134,880
+42,892
+47% +$55.7K ﹤0.01% 4990
2024
Q4 		$146K Buy
91,988
+48,759
+113% +$98K ﹤0.01% 4979
2024
Q3 		$84.7K Buy
43,229
+1,622
+4% +$3.32K ﹤0.01% 5116
2024
Q2 		$68.2K Buy
41,607
+6,306
+18% +$20.2K ﹤0.01% 5157
2024
Q1 		$181K Buy
35,301
+8,374
+31% +$51.6K ﹤0.01% 4532
2023
Q4 		$154K Sell
26,927
-85,483
-76% -$423K ﹤0.01% 4632
2023
Q3 		$537K Buy
112,410
+89,054
+381% +$552K ﹤0.01% 3729
2023
Q2 		$99.3K Sell
23,356
-27,210
-54% -$122K ﹤0.01% 5042
2023
Q1 		$269K Buy
50,566
+48,866
+2,874% +$304K ﹤0.01% 4258
2022
Q4 		$10.7K Sell
1,700
-1,061
-38% -$9.44K ﹤0.01% 5526
2022
Q3 		$29K Buy
2,761
+498
+22% +$4.64K ﹤0.01% 5205
2022
Q2 		$13K Sell
2,263
-12,349
-85% -$94.4K ﹤0.01% 5633
2022
Q1 		$134K Sell
14,612
-11,448
-44% -$121K ﹤0.01% 5187
2021
Q4 		$394K Buy
26,060
+24,758
+1,902% +$481K ﹤0.01% 4853
2021
Q3 		$31K Buy
+1,302
New +$31.8K ﹤0.01% 5804

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wells Fargo's CRBU Position: Q1 2026 in Review

Wells Fargo increased its Caribou Biosciences (CRBU) stake by 114% in Q1 2026, buying an estimated $278K and bringing the position to 303,655 shares worth $577K. The position accounts for ﹤0.01% of the portfolio, ranked #4079.

Wells Fargo first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Wells Fargo held 303,655 shares of Caribou Biosciences worth $577K as of Q1 2026.
  • Wells Fargo bought 161,712 Caribou Biosciences shares in Q1 2026, an estimated $278K.
  • Caribou Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4079 holding.
  • Wells Fargo first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.